London-based medical technology giant Smith & Nephew plc has announced the completion of its acquisition of Munich, Germany-based Brainlab’s orthopedic joint reconstruction business.
SNN Buys Brainlab Orthopedic Joint Reconstruction Business
1 min read Premium comments
Smith NephewSecondary#brainlab#navio
Brainlab develops, manufactures, and markets software-driven medical technology. Its core products focus on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange.
“The Brainlab orthopaedic joint reconstruction business provides surgeons with digital workflow tools, from pre-operative planning to intraoperative navigation to post-operative evaluation and sharing.…” Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma. Brainlab technologies are used in more than 500 hospitals worldwide.
Brainlab was formed in Munich, Germany in 1989. It employs almost 1,400 people in 18 offices worldwide.
Stefan Vilsmeier, president and CEO, Brainlab, said, “Computer-assisted surgery is the foundation of any powerful robotic solution and sophisticated software will drive superior robotic applications…I’m excited about co-inventing the future of digital surgery with our new partner, and expanding the reach of our technology to ambulatory surgery centers and their patients.”
“The acquisition supports Smith & Nephew’s strategy to invest in best-in-class technologies that further its multi-asset digital surgery and robotic ecosystem.”
“Smith & Nephew is a portfolio medical technology business with leadership positions in Orthopedics, Advanced Wound Management, and Sports Medicine. Smith & Nephew has more than 16,000 employees and a presence in more than 100 countries. Annual sales in 2018 were $4.9 billion.”
Namal Nawana, CEO of Smith & Nephew, said, “This partnership with Brainlab is a critical driver of our digital surgery and robotic ecosystem. Together we will drive the development and adoption of digital technologies to dramatically improve efficiency and outcomes in the OR.”
Smith & Nephew’s first priority will be to integrate Brainlab technology into NAVIO 7.0, the next version of its surgical robotics system.
The terms of the transaction were not disclosed.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.